141 related articles for article (PubMed ID: 6309795)
1. Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis.
Shukla SD; Buxton DB; Olson MS; Hanahan DJ
J Biol Chem; 1983 Sep; 258(17):10212-4. PubMed ID: 6309795
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine.
Buxton DB; Shukla SD; Hanahan DJ; Olson MS
J Biol Chem; 1984 Feb; 259(3):1468-71. PubMed ID: 6693418
[TBL] [Abstract][Full Text] [Related]
3. The effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 4,5-bisphosphate metabolism in rat hepatocytes.
Fisher RA; Shukla SD; Debuysere MS; Hanahan DJ; Olson MS
J Biol Chem; 1984 Jul; 259(14):8685-8. PubMed ID: 6086606
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of glycogenolysis and platelet-activating factor production by heat-aggregated immunoglobulin G in the perfused rat liver.
Buxton DB; Hanahan DJ; Olson MS
J Biol Chem; 1984 Nov; 259(22):13758-61. PubMed ID: 6501277
[TBL] [Abstract][Full Text] [Related]
5. Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Buxton DB; Hanahan DJ; Olson MS
Biochem Pharmacol; 1986 Mar; 35(6):893-7. PubMed ID: 3754140
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-adrenergic stimulation on 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Fisher RA; Kumar R; Hanahan DJ; Olson MS
J Biol Chem; 1986 Jul; 261(19):8817-23. PubMed ID: 3013865
[TBL] [Abstract][Full Text] [Related]
7. An early transient decrease in phosphatidylinositol 4,5-bisphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor).
Shukla SD; Hanahan DJ
Arch Biochem Biophys; 1983 Dec; 227(2):626-9. PubMed ID: 6320731
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Buxton DB; Fisher RA; Hanahan DJ; Olson MS
J Biol Chem; 1986 Jan; 261(2):644-9. PubMed ID: 3001074
[TBL] [Abstract][Full Text] [Related]
9. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway.
Altin JG; Dieter P; Bygrave FL
Biochem J; 1987 Jul; 245(1):145-50. PubMed ID: 3117040
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid.
Lapointe DS; Olson MS
J Biol Chem; 1989 Jul; 264(21):12130-3. PubMed ID: 2501299
[TBL] [Abstract][Full Text] [Related]
11. Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion.
Shukla SD; Hanahan DJ
Arch Biochem Biophys; 1984 Aug; 232(2):458-66. PubMed ID: 6465886
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of renin secretion by platelet activating factor (acetylglyceryl ether phosphorylcholine) in cultured rat renal juxtaglomerular cells.
Pfeilschifter J; Kurtz A; Bauer C
Biochem Biophys Res Commun; 1985 Mar; 127(3):903-10. PubMed ID: 2985064
[TBL] [Abstract][Full Text] [Related]
13. Location of platelet activating factor binding in rat liver.
Hill CE; Miwa M; Sheridan PJ; Hanahan DJ; Olson MS
Biochem J; 1988 Aug; 253(3):651-7. PubMed ID: 3178735
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of hepatic calcium pools by platelet activating factor.
Lapointe DS; Hanahan DJ; Olson MS
Biochemistry; 1987 Mar; 26(6):1568-74. PubMed ID: 3593678
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of uric acid release from the perfused rat liver by platelet activating factor or potassium.
Hill CE; Olson MS
Biochem J; 1987 Oct; 247(1):207-14. PubMed ID: 3689345
[TBL] [Abstract][Full Text] [Related]
16. Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.
Levi R; Burke JA; Guo ZG; Hattori Y; Hoppens CM; McManus LM; Hanahan DJ; Pinckard RN
Circ Res; 1984 Feb; 54(2):117-24. PubMed ID: 6692502
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit.
McManus LM; Fitzpatrick FA; Hanahan DJ; Pinckard RN
Immunopharmacology; 1983 Feb; 5(3):197-207. PubMed ID: 6832960
[TBL] [Abstract][Full Text] [Related]
18. Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.
Heffner JE; Shoemaker SA; Canham EM; Patel M; McMurtry IF; Morris HG; Repine JE
J Clin Invest; 1983 Feb; 71(2):351-7. PubMed ID: 6822668
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine on calcium fluxes by human platelet microsomes.
White GC
Biochem Biophys Res Commun; 1984 Apr; 120(2):474-80. PubMed ID: 6428395
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619.
Fisher RA; Robertson SM; Olson MS
J Biol Chem; 1987 Apr; 262(10):4631-8. PubMed ID: 3558359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
